KDR and renal carcinoma: To evaluate whether the methylation statuses of VEGF, FLT1, or KDR of renal cancer tissues are related to patient responses to sunitinib, we compared the methylation statuses of these targets in cancer tissues from 13 patients with RCC who were treated with sunitinib.